Michael J. Farrell - Nov 10, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Nov 10, 2022
Transactions value $
-$1,077,650
Form type
4
Date filed
11/14/2022, 10:56 AM
Previous filing
Oct 18, 2022
Next filing
Nov 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Gift $0 -1K -19.65% $0.00 4.09K Nov 10, 2022 Lisette and Michael Farrell Family Trust F1
transaction RMD ResMed Common Stock Gift $0 +1K +25.77% $0.00 4.88K Nov 10, 2022 Lisette and Michael Farrell Foundation F2
transaction RMD ResMed Common Stock Sale -$1.08M -4.88K -100% $220.83 0 Nov 10, 2022 Lisette and Michael Farrell Foundation F3
holding RMD ResMed Common Stock 423K Nov 10, 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gift of shares transferred to The Lisette and Michael Farrell Foundation, Mr. Farrell retains dispositive power over remaining shares.
F2 Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.
F3 This transaction was executed in multiple trades at prices ranging from $220.67 $220.97. The price reported above reflects the weighted average sale price.
F4 Includes 84.179 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.